Share the post "Auro Laboratories : Q4 2024 Financial Quarterly Report : YoY Sales Down 10.81 %, QoQ Down 32.9 %"
Highlights
- Sales over the Year and quarter: The company’s sales declined by -10.81 % over the year, decrease in net sales/revenue by -32.9 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -35.48 %, Marginal decrease of -4.76% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Auro Laboratories Ltd.. Notable increase of 30.17 % in net profit Year to Year, Auro Laboratories Ltd.’s profitability dropped by -15.11 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 30.07 % Year to Year. EPS decreased by -15.26 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 13.525 Cr | Rs. 17.978 Cr | Rs. 12.063 Cr | -32.9 % | -10.81 % |
| Expenses | Rs. 11.18 Cr | Rs. 13.89 Cr | Rs. 9 Cr | -35.21 % | -19.5 % |
| Operating Profit | Rs. 2.35 Cr | Rs. 4.09 Cr | Rs. 3.06 Cr | -25.18 % | + 30.21 % |
| OPM % | 17.38 % | 22.75 % | 25.37 % | + 2.62 % | + 7.99 % |
| Other Income | Rs. 0.62 Cr | Rs. 0.42 Cr | Rs. 0.4 Cr | -4.76 % | -35.48 % |
| Interest | Rs. 0.13 Cr | Rs. 0.45 Cr | Rs. 0.33 Cr | -26.67 % | + 153.85 % |
| Depreciation | Rs. 0.3 Cr | Rs. 0.27 Cr | Rs. 0.28 Cr | + 3.7 % | -6.67 % |
| Profit before tax | Rs. 2.54 Cr | Rs. 3.79 Cr | Rs. 2.85 Cr | -24.8 % | + 12.2 % |
| Tax % | 29.62 % | 27.82 % | 18.59 % | -9.23 % | -11.03 % |
| Net Profit | Rs. 1.78 Cr | Rs. 2.73 Cr | Rs. 2.32 Cr | -15.02 % | + 30.34 % |
| EPS in Rs | Rs. 2.86 | Rs. 4.39 | Rs. 3.72 | -15.26 % | + 30.07 % |
Today, we’re looking at Auro Laboratories Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -10.81 %. However, it did see a marginal slip of -32.9 % from the previous quarter. Expenses decreased slightly by -35.21 % quarter-on-quarter, aligning with the annual decline of -19.5 %. Operating profit, while up 30.21 % compared to last year, faced a quarter-on-quarter dip of -25.18 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 7.99 %, but an expansion of 2.62 % sequentially. Other income fell by -4.76 % compared to the last quarter, despite an annual decline of -35.48 %. Interest expenses dropped significantly by -26.67 % from the previous quarter, yet the year-over-year increase remains at a moderate 153.85 %. Depreciation costs climbed by 3.7 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -6.67 %. Profit before tax grew annually by 12.2 % but saw a reduction from the preceding quarter by -24.8 %.
Tax expenses as a percentage of profits decreased slightly by -11.03 % compared to last year, with a more notable quarter-on-quarter decrease of -9.23 %. Net profit rose by 30.34 % year-on-year but witnessed a -15.02 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 30.07 % but a quarterly fall of -15.26 %. In summary, Auro Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 13.525 Cr | Rs. 17.978 Cr | Rs. 12.063 Cr | -32.9 % | -10.81 % |
| Expenses | Rs. 11.18 Cr | Rs. 13.89 Cr | Rs. 9 Cr | -35.21 % | -19.5 % |
| Operating Profit | Rs. 2.35 Cr | Rs. 4.09 Cr | Rs. 3.06 Cr | -25.18 % | + 30.21 % |
| Net Profit | Rs. 1.78 Cr | Rs. 2.73 Cr | Rs. 2.32 Cr | -15.02 % | + 30.34 % |
| EPS in Rs | Rs. 2.86 | Rs. 4.39 | Rs. 3.72 | -15.26 % | + 30.07 % |
In reviewing Auro Laboratories Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -10.81 % year-on-year, although there was a slight dip of -32.9 % from the previous quarter. Expenses decreased by -19.5 % compared to the previous year, with a decrease of -35.21 % quarter-on-quarter. Operating Profit surged by 30.21 % annually, and saw a -25.18 % decrease from the last quarter.
Net Profit showed yearly increase of 30.34 %, and experienced a -15.02 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 30.07 % annually, however dipped by -15.26 % compared to the last quarter. In essence, while Auro Laboratories Ltd. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
